Photo via New York Post

GLP-1 use is way up in a key demographic — rates are 24x higher than in 2018

Read the original at New York Post ↗
Cite

Yang, A. (2026, October 3). GLP-1 use is way up in a key demographic — rates are 24x higher than in 2018. New York Post. https://nypost.com/2026/10/03/health/glp-1-use-skyrocketed-24x-in-a-key-demographic/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

New York Post · collected 2026-10-03 · by Allie Yang

Quick Summary

No summary of this article yet; the story summary below covers the event.

AI analysis

Story summary

In a recent study examining 1 million births, researchers found that new mothers with type 2 diabetes are increasingly using GLP-1 medications like Ozempic, Wegovy, and Mounjaro. The use of these drugs among such patients surged from 2.3% in 2018 to 16.9% by 2025, meaning about one in six new mothers with diabetes are now on GLP-1s within half a year after giving birth. This marks a significant increase, reflecting a 24-fold rise from the starting point of just .8% in 2018. Overall, usage among US adults for weight loss has risen dramatically to 11%, with women accounting for up to 70% of GLP-1 users due to its benefits beyond diabetes management, including weight loss and reduced risk of depression, dementia, cancer, heart attacks, and substance abuse.

Written for “GLP-1 Medication Usage Growth” on 2026-11-04, grounded in this article and the 0 other(s) covering the same event.

Story

📰 GLP-1 Medication Usage Growth
Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 8% of its claims. Each row says how that neighbour differs.
Daily Mail
Hedges 3 of 41 claims Outlet record 69/100
“The articles discuss different aspects of weight-loss medications but do not describe the same specific incident or occurrence.”
TIME
Hedges 1 of 15 claims Outlet record 59/100
“The articles discuss different drugs and their effects; one focuses on Eli Lilly's experimental retatrutide while the other discusses GLP-1 medications like Ozempic, Wegovy, and Mounjaro.”
NBC News
Hedges 7 of 34 claims Outlet record 78/100
“The articles discuss different aspects of GLP-1 drugs but do not describe the same specific incident or trial results.”
Toronto Star
Hedges 7 of 66 claims Outlet record 64/100
“Article A describes results from a specific clinical trial for survodutide, while Article B discusses general trends in GLP-1 medication use across the US population.”
The Independent
Hedges 3 of 17 claims Outlet record 59/100
“Article A focuses specifically on new mothers receiving GLP-1 drugs after giving birth, while Article B discusses broader use among US adults for weight loss.”
Daily Mail
Hedges 10 of 32 claims Outlet record 69/100
“The articles discuss different aspects of weight loss medications without describing the same specific incident.”
New York Post
Hedges 0 of 23 claims Outlet record 66/100
“The articles discuss different aspects of weight loss drugs but do not describe the same specific incident or outcome.”
The Straits Times
Hedges 9 of 27 claims Outlet record 66/100
“The articles discuss different aspects of GLP-1 medications and weight loss drugs: one focuses on usage rates among US adults, while the other mentions potential Nobel Prize recognition for research related to these drugs.”
TIME
Hedges 19 of 132 claims Outlet record 59/100
“Article A discusses the overall increase in GLP-1 medication use among US adults, while Article B focuses on an individual's experience with a compounding pharmacy for obtaining GLP-1 drugs.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
25
sentences that state something as happening or true
Uncertain
8%
2 of 25 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
66/100
New York Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-03 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

New York Post · 16932 article(s) · 36 correction(s) detected
Running correction rate · 36 correction(s)

Who wrote this

Allie Yang
38 article(s) here · 1 carrying a prediction
🔮 How could this happen to someone in “perfect health, perfect shape,” as her dad described?
🔮 Wietrzyk will be participating in the Elite 15, a series of competitions to qualify for the Hyrox World Championships.
🔮 However, they say those thresholds may be outdated — particularly for BPA, which they observed at relatively high levels.
🔮 The lump grew so large she “couldn’t even zip my jacket up …
🔮 If you need to go under the knife, a key tool to prepare could already be in your bedside table.
🔮 What researchers found USC researchers had a group of 365 fish-averse adults, 55 to 80 years old and at increased risk for Alzheimer’s, take fish oil daily to see if it would help them avoid cognitive decline over the course of two years.
🔮 Since 2018, an unbearable “shocking, throbbing pain” would course through her face at random, lasting from seconds to minutes each time. “When I got my shocks, it was all-in-one, everything hit me,” she told The Post.
🔮 His advice is for teens and folks of all ages: Keep a good nighttime routine and sleep hygiene — and your body will thank you.
🔮 That disruption may become permanent, and patients can lose the ability to walk on their own or move at all.
🔮 But Dr. Amy Novatt, an OB-GYN at the sexual wellness brand Dame, warns that this particularly freaky fetish should stay a daydream — because any real-life exploration could go catastrophically wrong.
Also by Allie Yang
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 38 articles by Allie Yang →

Topics

Mounjaro Ozempic Wegovy

Subjects

No subjects extracted.

Narrative

Researchers in this new study looked at 1 million births and tracked which moms started on GLP-1s within half a year. They found that within the group, new moms with type 2 diabetes got the most prescriptions (increasing from 2.3% to 16.9%, or about one in six patients) between 2018 and 2025.
framing: assertive · carried by 1 article(s) · first seen 2026-10-03
🔮 Gestational diabetes happens in 5% to 9% of pregnancies in the US and gives a strong indication mom will develop diabetes later in life.

Claims (25 extracted, 2 hedged)

This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11% — meaning more than one in 10 adults are on one form or another of the jab. asserted
adults → reach → jab
This explosion in use of drugs like Ozempic, Wegovy and Mounjaro has happened over a very short time — about five years — despite the drugs being on the market for over two decades. asserted
drugs → happen → decades
People are on it because it works. asserted
it → work → it
Patients lose, on average, 7 to 11% of their starting weight. asserted
Patients → lose → weight
Still, people are mainly on it to shed pounds — including one demographic in particular, whose use of the drug has skyrocketed from .8% in 2018 to 1.9% in 2025 — a 24-fold increase. asserted
use → shed → 2025
They are new mothers, specifically women who get on the drug within six months of giving birth, new research found. asserted
research → get → birth
This research sheds new light on the larger demographic differences in GLP-1 use. asserted
research → shed → use
Women use GLP-1s much more than men overall, making up as much as 70% of patients on the drug. asserted
Women → use → drug
Researchers in this new study looked at 1 million births and tracked which moms started on GLP-1s within half a year. They found that within the group, new moms with type 2 diabetes got the most prescriptions (increasing from 2.3% to 16.9%, or about one in six patients) between 2018 and 2025. asserted
moms → look → 2018
But those who had gestational diabetes — temporary diabetes that develops during pregnancy — also increased GLP-1 scripts dramatically, from .4 in 2021 to 2.7% in 2025. asserted
that → have → 2025
Gestational diabetes happens in 5% to 9% of pregnancies in the US and gives a strong indication mom will develop diabetes later in life. asserted
mom → happen → life
As many as 50-70% of women who have gestational diabetes develop type 2 diabetes later. asserted
who → have → diabetes
The fastest increase, however, was among women diagnosed as obese or overweight before pregnancy. asserted
increase → diagnose → pregnancy
Their GLP-1 scripts jumped from from 0.4% in 2021 to 3.9% in 2025 — nearly a tenfold increase. asserted
scripts → jump → 2025
This touches on one of the biggest reasons overall GLP-1 use has exploded in recent years. asserted
use → touch → years
GLP-1s weren’t always approved for weight loss — it was mainly used to help people with diabetes manage their blood sugar. asserted
people → approve → sugar
But in 2021 that changed, opening the door to people who struggled with weight and obesity, kickstarting the frenzy we’re seeing now. asserted
we → change → frenzy
Authors note that like gestational diabetes potentially causing problems down the road, weight gained during pregnancy can be hard to lose long after birth. asserted
weight → note → birth
Twelve months after birth, up to 75% of women weigh more than they did before pregnancy. asserted
they → weigh → pregnancy
This extra weight contributes to issues with blood pressure, cholesterol, and insulin resistance. asserted
weight → contribute → pressure
One study even suggests that keeping the weight on one year after birth is an indicator they’ll weigh more 15 years down the line. uncertain
they → suggest → line
GLP-1s are generally avoided during pregnancy though, which helps explain why use skyrockets within six months after birth. asserted
use → avoid → birth
Authors of the new study note it can be an important medication to manage long term risks associated with weight retention and diabetes. asserted
it → note → retention
However, given that moms are starting so soon after giving birth, authors are calling for more research on how GLP-1s might affect breastfeeding. uncertain
GLP-1s → give → breastfeeding
One study showed that GLP-1s were not detectable in breast milk, but experts still advise caution and many do not advise using the drug while breastfeeding. asserted
many → show → drug
💬Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

🕘History 🎫Support